Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis-inhibition of aflatoxin B1 metabolism

Toxicology and Applied Pharmacology

Volumn 227, Issue 3, 2008, Pages 339-346

  Guarisco, John A ^a   Hall, Jeffery O ^a   Coulombe Jr , Roger A ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

Aflatoxin B1; BHT; Chemoprevention; Cytochrome P450; Turkeys

Indexed keywords

AFLATOXIN B1; BUTYLCRESOL; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; ETHOXYRESORUFIN DEETHYLASE; NIFEDIPINE;

ABDOMINAL FAT; AFLATOXICOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FOOD AND DRUG ADMINISTRATION; IN VIVO STUDY; INFECTION PREVENTION; LIVER MICROSOME; MALE; NONHUMAN; OXIDATION; TURKEY (BIRD); UNITED STATES;

AFLATOXIN B1; ANIMALS; ANTIOXIDANTS; BUTYLATED HYDROXYTOLUENE; CHEMOPREVENTION; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; LIVER; MICROSOMES, LIVER; NIFEDIPINE; OXIDOREDUCTASES; TISSUE DISTRIBUTION; TURKEYS;

ANIMALIA; AVES; RODENTIA;

EID: 39849097506     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.11.017     Document Type: Article

References (38)

1. Blum C.A., Xu M., Orner G.A., Dario Diaz G., Li Q., Dashwood W.M., Bailey G.S., and Dashwood R.H. Promotion versus suppression of rat colon carcinogenesis by chlorophyllin and chlorophyll: modulation of apoptosis, cell proliferation, and beta-catenin/Tcf signaling. Mutat. Res. (2003) 523-524
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparanta T., and Mayer R.T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34 (1985) 3337-3345
4. Coulombe Jr. R.A. Biological action of mycotoxins. J. Dairy Sci. 76 (1993) 880-891
5. Crivello J.F. Interaction of bovine renal mitochondrial cytochrome P-450 with antioxidants. Arch. Biochem. Biophys. 248 (1986) 551-561
6. Dashwood R.H., Fong A.T., Williams D.E., Hendricks J.D., and Bailey G.S. Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res. 51 (1991) 2362-2365
7. Edds G.T. Acute aflatoxicosis: a review. J. Am. Vet. Med. Assoc. 162 (1973) 304-309
8. Egner P.A., Wang J.B., Zhu Y.R., Zhang B.C., Wu Y., Zhang Q.N., Qian G.S., Kuang S.Y., Gange S.J., Jacobson L.P., Helzlsouer K.J., Bailey G.S., Groopman J.D., and Kensler T.W. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14601-14606
9. Frawley J.P., Kay J.H., and Calandra J.C. The residue of butylated hydroxytoluene (BHT) and metabolites in tissue and eggs of chickens fed diets containing radioactive BHT. Food Cosmet. Toxicol. 3 (1965) 471-474
10. 1. Cancer Res. 54 (1994) 101-108
11. Giambrone J.J., Diener U.L., Davis N.D., Panangala V.S., and Hoerr F.J. Effect of purified aflatoxin on turkeys. Poult. Sci. 64 (1985) 859-865
12. Grantham P.H., Weisburger J.H., and Weisburger E.K. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide. Food Cosmet. Toxicol. 11 (1973) 209-217
13. Greenwald P. Clinical trials in cancer prevention: current results and perspectives for the future. J. Nutr. 134 (2004) 3507S-3512S
14. Hathway D.E. Metabolic fate in animals of hindered phenolic antioxidants in relation to their safety evaluation and antioxidant function. Adv. Food Res. 15 (1966) 1-56
15. Hocman G. Chemoprevention of cancer: phenolic antioxidants (BHT BHA). Int. J Biochem. 20 (1988) 639-651
16. Kelly J.D., Eaton D.L., Guengerich F.P., and Coulombe Jr. R.A. Aflatoxin B1 activation in human lung. Toxicol. Appl. Pharmacol. 144 (1997) 88-95
17. Klein P.J., Buckner R., Kelly J., and Coulombe Jr. R.A. Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B1. Toxicol. Appl. Pharmacol. 165 (2000) 45-52
18. 1. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. 132 (2002) 193-201
19. Klein P.J., Van Vleet T.R., Hall J.O., and Coulombe Jr. R.A. Effects of dietary butylated hydroxytoluene on aflatoxin B1-relevant metabolic enzymes in turkeys. Food Chem. Toxicol. 41 (2003) 671-678
20. Lanigan R.S., and Yamarik T.A. Final report on the safety assessment of BHT. Int. J. Toxicol. 21 Suppl 2 (2002) 19-94
21. Larsen C., Ehrich M., Driscoll C., and Gross W.B. Aflatoxin-antioxidant effects on growth of young chicks. Poult. Sci. 64 (1985) 2287-2291
22. Levine W.G. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes. Res. Commun. Chem. Pathol. Pharmacol. 46 (1984) 113-120
23. Lubet R.A., Mayer R.T., Cameron J.W., Nims R.W., Burke M.D., Wolff T., and Guengerich F.P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238 (1985) 43-48
24. Mayura K., Abdel-Wahhab M.A., McKenzie K.S., Sarr A.B., Edwards J.F., Naguib K., and Phillips T.D. Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents: potential for hidden risks. Toxicol. Sci. 41 (1998) 175-182
25. McLellan L.I., Judah D.J., Neal G.E., and Hayes J.D. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors. Biochem. J. 300 (1994) 117-124
26. Monroe D.H., and Eaton D.L. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse. Toxicol. Appl. Pharmacol. 90 (1987) 401-409
27. Powell C.J., Connelly J.C., Jones S.M., Grasso P., and Bridges J.W. Hepatic responses to the administration of high doses of BHT to the rat: their relevance to hepatocarcinogenicity. Food Chem. Toxicol. 24 (1986) 1131-1143
28. 1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res. 50 (1990) 615-620
29. Safer A.M., and al-Nughamish A.J. Hepatotoxicity induced by the anti-oxidant food additive, butylated hydroxytoluene (BHT), in rats: an electron microscopical study. Histol. Histopathol. 14 (1999) 391-406
30. Segel I.H. Biochemical Calculations: How to Solve Mathematical Problems in General Biochemistry (1976), Wiley, New York
31. Singletary K.W. Effect of dietary butylated hydroxytoluene on the in vivo distribution, metabolism and DNA-binding of 7,12-dimethylbenz[a]anthracene. Cancer Lett. 49 (1990) 187-193
32. Sporn M.B., and Liby K.T. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat. Clin. Pract. Oncol. 2 (2005) 518-525
33. Sun B., Fukuhara M., Kinoshita T., Kimura M., and Ushio F. Differential induction of isozymes of drug-metabolizing enzymes by butylated hydroxytoluene in mice and Chinese hamsters. Food Chem. Toxico.l 34 (1996) 595-601
34. Terao J., Magarian R.A., Brueggemann G., and King M.M. Methods of extraction and high-performance liquid chromatographic analysis of butylated hydroxytoluene from the tissues and serum of rats. Anal. Biochem. 151 (1985) 445-454
35. Tilton S.C., Hendricks J.D., Orner G.A., Pereira C.B., Bailey G.S., and Williams D.E. Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3′-diindolylmethane, in rainbow trout. Carcinogenesis 28 (2007) 1589-1598
36. Ulland B.M., Weisburger J.H., Yamamoto R.S., and Weisburger E.K. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet. Toxicol. 11 (1973) 199-207
37. Williams G.M., and Iatropoulos M.J. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett. 104 (1996) 49-53
38. Yip S.S., and Coulombe Jr. R.A. Molecular cloning and expression of a novel cytochrome P450 from turkey liver with aflatoxin B1 oxidizing activity. Chem. Res. Toxicol. 19 (2006) 30-37